


Ask a doctor about a prescription for RANOZEK 375 MG PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the Patient
Ranozek 375 mg prolonged-release tablets EFG
Ranozek 500 mg prolonged-release tablets EFG
Ranozek 750 mg prolonged-release tablets EFG
ranolazine
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Ranozek is a medication used in combination with others for the treatment of angina pectoris, which is a disease that causes chest pain or discomfort felt in any part of the upper half of the body between the neck and the upper part of the abdomen, often after physical exercise or a particularly intense activity.
You should consult a doctor if it worsens or does not improve.
Do not take Ranozek
Warnings and precautions
Consult your doctor before taking this medication:
If you are in any of these situations, your doctor may decide to give you a lower dose of the medication or take other precautions.
Other medications and Ranozek
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Do not use any of the following medications if you are taking Ranozek:
Tell your doctor or pharmacist before taking this medication if you are using:
Taking Ranozek with food and drinks
This medication can be taken with or without food. While you are being treated with this medication, you should not drink grapefruit juice.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not take this medication if you are pregnant unless your doctor has told you to do so.
Breastfeeding
Do not take this medication if you are breastfeeding. Ask your doctor for advice if you are breastfeeding.
Driving and using machines
No studies have been conducted on the effects of this medication on the ability to drive and use machines. Ask your doctor if you can drive or use machines.
This medication may cause side effects such as dizziness (frequent), blurred vision (uncommon), confusion (uncommon), hallucinations (uncommon), double vision (uncommon), coordination problems (rare), which may affect your ability to drive or use machines. If you notice any of these symptoms, do not drive or use machines until they have passed.
Ranozek contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow your doctor's or pharmacist's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
Always swallow the tablets whole with water. Do not chew, suck, or crush the tablets, or divide them in half, as this may affect the way the medication is released in your body.
The initial dose for adults is one 375 mg tablet twice a day. After a period of 2 to 4 weeks, your doctor may increase the dose to achieve the desired effect. The maximum dose of this medication is 750 mg twice a day.
It is essential that you inform your doctor if you experience side effects such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or tell you to stop taking this medication.
Use in children and adolescents
Children and adolescents under 18 years of age should not take this medication.
If you take more Ranozek than you should
If you accidentally take more tablets of this medication than you should, or take tablets of a higher dose than recommended by your doctor, it is essential that you inform your doctor immediately. If you cannot contact your doctor, go to the nearest emergency center. Take the remaining tablets, along with the blister pack and packaging, so that hospital staff can easily see what you have taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Ranozek
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose (less than 6 hours). Do not take a double dose to make up for forgotten doses.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
You should stop taking this medication and consult your doctor immediately if you experience the following symptoms of angioedema, which is a rare but potentially serious disorder:
Tell your doctor if you experience frequent side effects such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or tell you to stop taking this medication.
Other side effects you may experience include:
Frequent side effects(may affect up to 1 in 10 people):
Constipation
Dizziness
Headache
Nausea, vomiting
Weakness (asthenia)
Uncommon side effects(may affect up to 1 in 100 people):
Altered sensitivity
Anxiety, difficulty sleeping, confusion, hallucinations
Blurred vision, vision disorders
Sensory disturbances (touch or taste), tremors, fatigue or weakness, somnolence or lethargy, weakness or fainting, dizziness when standing up
Dark urine, blood in the urine, difficulty urinating
Dehydration
Breathing difficulties, cough, nosebleeds
Double vision
Excessive sweating, itching
Feeling of swelling or bloating
Hot flashes, low blood pressure
Increased levels of a substance called creatinine or urea in the blood, increased platelet or white blood cell counts, altered electrocardiogram (ECG)
Swollen joints, pain in the limbs
Loss of appetite and/or weight loss
Muscle cramps, muscle weakness
Ringing in the ears and/or feeling of spinning
Stomach pain or discomfort, indigestion, dry mouth, or gas
Rare side effects(may affect up to 1 in 1,000 people):
Urinary retention
Abnormal liver laboratory values
Acute kidney failure
Disturbances in the sense of smell, numbness of the mouth or lips, hearing loss
Cold sweats, rash
Coordination problems
Low blood pressure when standing up
Decreased level of consciousness or loss of consciousness
Disorientation
Feeling of cold in hands and feet
Hives, allergic skin reactions
Impotence
Inability to walk due to balance problems
Pancreatitis or intestinal inflammation
Memory loss
Throat tightness
Low sodium levels in the blood (hyponatremia) that can cause fatigue and confusion, muscle contractions, cramps, and coma.
Frequency not known(frequency cannot be estimated from available data):
Myoclonus
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the blister pack and carton after EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to a pharmacy for proper disposal. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Ranozek
The active ingredient of Ranozek is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg of ranolazine.
The other ingredients are:
Core of the tablet: microcrystalline cellulose (E460), methacrylic acid-ethyl acrylate copolymer (1:1), sodium hydroxide (E524), hypromellose (E464), and magnesium stearate (E470b).
White AquaPolish coating: hypromellose (E464), hydroxypropylcellulose (E463), macrogol 8000 (E1521), and titanium dioxide (E171).
Appearance of the product and pack contents
The 375 mg tablets are white, oval, convex, film-coated tablets, 15 mm x 7.2 mm in size, and have "375" engraved on one side.
The 500 mg tablets are white, oval, convex, film-coated tablets, 16.5 mm x 8.0 mm in size, and have "500" engraved on one side.
The 750 mg tablets are white, oval, convex, film-coated tablets, 19 mm x 9.2 mm in size, and have "750" engraved on one side.
Ranozek is available in boxes containing 30, 60, or 100 tablets in PVC/PVDC-Aluminum blisters.
Not all pack sizes may be marketed.
Marketing authorization holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2ª planta
28023 Madrid
Manufacturer
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medication is authorized inthe Member States of the European Economic Area under the following names:
Member State | Medication name |
Netherlands | Ranozek 375 mg prolonged-release tablets Ranozek 500 mg prolonged-release tablets Ranozek 750 mg prolonged-release tablets |
Germany | Ranozek 375 mg retard tablets Ranozek 500 mg retard tablets Ranozek 750 mg retard tablets |
Latvia | Ranozek 375 mg prolonged-release tablets Ranozek 500 mg prolonged-release tablets Ranozek 750 mg prolonged-release tablets |
Poland | Ranozek |
Italy | Ranozek |
Spain | Ranozek 375 mg prolonged-release tablets EFG Ranozek 500 mg prolonged-release tablets EFG Ranozek 750 mg prolonged-release tablets EFG |
Date of the last revision of this package leaflet: May 2022
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es.
The average price of RANOZEK 375 MG PROLONGED-RELEASE TABLETS in December, 2025 is around 20.87 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for RANOZEK 375 MG PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.